Glucoside hydrolase inhibitors prodn. from bacteria - esp. Bacillus species useful, e.g., for increasing meat yields and feed efficiency

The use of microorganisms of the family Bacillaceae to make glucoside-hydrolase inhibitors (I) is new. Pref. species are Bacillus subtilis, B. subtilis var. niger, B. amyloliquefaciens, B. coagulans, B. longisporus and B. polymyxa, specifically the strains DSM 292, 356, 36, 740, 741, 1, 479, 365, 74...

Full description

Saved in:
Bibliographic Details
Main Authors FROMMER,WERNER,DR, KRAUSE,HANS-PETER,DR, MUELLER,LUTZ,.DR, PULS,WALTER,DR, HEBER,U.,DR, SCHMIDT,DELF,.DR
Format Patent
LanguageEnglish
German
Published 29.06.1978
Edition2
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The use of microorganisms of the family Bacillaceae to make glucoside-hydrolase inhibitors (I) is new. Pref. species are Bacillus subtilis, B. subtilis var. niger, B. amyloliquefaciens, B. coagulans, B. longisporus and B. polymyxa, specifically the strains DSM 292, 356, 36, 740, 741, 1, 479, 365, 742, 7, 372, 675, 704, 1060, 1061, 1062, 1063, 1064, 1065, 1066 and 1067. The strains DSM 7, 704, 675 and 372 are used to produce 1-deoxynojirimycin. DSM 704, 740, 741, and 742 are claimed as new strains. (I) inhibit saccharase more effectively than known inhibitors; that from DSM 479 also inhibits amylase. When administered to animals they prevent undesirable accumulation of fat, improve feed utilisation and increase the proportion of lean meat. They are also useful in human medicine for treating obesity, hyperglycaemia, constipation etc.
Bibliography:Application Number: DE19762658563